Global Primary Cells Market Poised to Witness a Strong Growth over 2023
The global primary cells market to exhibit a strong growth between 2018 and 2023. Market Research Future (MRFR) reports that the global primary cells market is poised to at a compound annual growth rate (CAGR) of 9.5% during the projection period. Advanced and safe mechanical or enzymatic method are used to isolate cells from human or blood cells. Primary cells are engaged in a vast category of cell-based research owing to their pertinent cellular functions.
Request Free Sample @ https://www.marketresearchfuture.com/sample_request/6296
Increased research activities focused on biopharmaceutical discovery and biotechnology, increased investment in cancer research, growing demand for monoclonal antibodies and higher healthcare expenditure are some of the key factor influencing the global primary cells market. Primary human cells are preferred over cell lines which also remains a positive factor. Unlike endothelial cell lines, endothelial cells retain most functional markers. Primary cells being a novel technology is relatively more expensive. At the same time, issue of cell contamination is yet to be effectively addressed.
Primary Cells Market Competitive Landscape
Some of the leading companies operating in the global Cell Biologics (US), ZenBio, Inc. (US), ALLCells (US), Axol Biosciences (UK), Thermo Fisher Scientific (US), Merck KGaA (Germany), Lonza (Switzerland), American Type Culture Collection (ATCC) (US), Promocell (Germany) and STEMCELL Technologies (Canada).
Primary Cells Market: Segmental Overview
MRFR’s report includes an in-depth segmental analysis of the global primary cell market based on type, origin and end user.
Based on type, the market has been segmented into animal primary cells and human primary cells. Based on origin, the market has been segmented into hematopoietic cells, liver cells, renal cells, skeletal and muscle cells, skin cells, gastrointestinal cells, lung cells, heart and others. Based on end-user, the market has been segmented into life science research companies and research institutes.
Global Primary Cells Market: Regional Segmentation
Based on region, the market has been segmented into Europe, Americas, the Middle East and Africa (MEA), and Asia Pacific (APAC). The Americas cells market cover both South America and North America. The Europe primary cells market covers Eastern Europe and Western Europe. Key countries covered in the Asia Pacific primary cells market include China, South Korea, Japan, Australia, and India. In terms of revenue, North America and South America collectively dominate the global primary cells market. Some of the key factors supporting the growth of the market in Americas include strong government backing for R&D, easy access to latest medical technologies and increased prevalence of cancer. Data released by National Cancer Institute revealed that nearly 1,685,210 new cases of cancer were recorded in the US in 2016.
Europe in holds the second spot in terms of value. Healthcare remains a major area of focus for the EU. Over the years, several policies have been launched to improve health care services in the region. Advanced countries in Europe present attractive growth opportunities for market players. In 2016, the gross domestic expenditure on R&D activities was more than Euro 33 Bn as per the office for National Statistics.
APAC is viewed as an emerging market for primary cells. The healthcare sector in APAC is witnessing tremendous growth, which is translating into opportunities for market players. Rising number of cancer cases, introduction favourable policies and pharmaceutical outsourcing are some of the factors supporting the market growth in APAC. Spending on medical science R&D institutes have surged in countries such as China and India, which is paving the way for the market to growth. The market in MEA is also expected to grow at a healthy pace but from a lower base. Many of the countries in MEA face issues such as underdeveloped healthcare infrastructure, limited access to services, etc.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Primary Cells Market, By Origin
6.2 Skin Cells
6.3 Hematopoietic Cells
LIST OF TABLES
Table 1 Global Primary Cells Market Synopsis, 2018–2023
Table 2 Global Primary Cells Market Estimates And Forecast, 2018–2023 (USD Million)
Table 3 Global Primary Cells Market, By Region, 2018–2023 (USD Million)
Table 4 Global Primary Cells Market, By Origin, 2018–2023 (USD Million)
Table 5 Global Primary Cells Market, By Type, 2018–2023 (USD Million)
Table 6 Global Primary Cells Market, By End-User, 2018–2023 (USD Million)
Table 7 North America: Primary Cells Market, By Origin, 2018–2023 (USD Million)
Table 8 North America: Primary Cells Market, By Type, 2018–2023 (USD Million)
Browse Complete 100 Pages Premium Research Report Enabled with 40+ Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/primary-cells-market-6296
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312